Brief: Autolus Therapeutics Reports First Quarter 2022 Financial Results
05/05/2022 12:24
May 5 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND OPERATIONAL PROGRESS
* Q1 LOSS PER SHARE $0.41
* Q1 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1W8JBJ
Further company coverage: AUTL.O
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants